Invention Grant
US08017602B2 N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy
失效
乙基氨基）乙基）-3-（苯乙氧基）-2-（2-（2-（2-羟基-3-氧代-3,4-二氢-2H-苯并[b] [1,4]恶嗪-8-基） 丙酰胺衍生物，其制备方法，含有它们的药物组合物及其在治疗中的用途
![N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy](/docs/US/2011-09-13/US08017602B2/abs.jpg.600x600.jpg)
- Patent Title: N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy
- Patent Title (中): 乙基氨基）乙基）-3-（苯乙氧基）-2-（2-（2-（2-羟基-3-氧代-3,4-二氢-2H-苯并[b] [1,4]恶嗪-8-基） 丙酰胺衍生物，其制备方法，含有它们的药物组合物及其在治疗中的用途
-
Application No.: US12486854Application Date: 2009-06-18
-
Publication No.: US08017602B2Publication Date: 2011-09-13
- Inventor: Roger Victor Bonnert , Stephen Connolly , Anthony Ronald Cook , Richard Evans , Piotr Raubo
- Applicant: Roger Victor Bonnert , Stephen Connolly , Anthony Ronald Cook , Richard Evans , Piotr Raubo
- Applicant Address: SE S{umlaut over (0)}dertälje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE S{umlaut over (0)}dertälje
- Agency: Connolly Bove Lodge & Hutz LLP
- Main IPC: C07D265/36
- IPC: C07D265/36 ; A61K31/536 ; A61K31/56
![N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy](/abs-image/US/2011/09/13/US08017602B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides a compound of formula (I) wherein W, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Public/Granted literature
- US20100105642A1 NOVEL COMPOUNDS 409 Public/Granted day:2010-04-29
Information query
